Jupiter Life Line Hospitals

On consolidated basis

Quarter ended September 2025 compared with Quarter ended September 2024.

Net sales (including other operating income) of Jupiter Life Line Hospitals has increased 17.48% to Rs 393.63 crore.''Operating profit margin has jumped from 23.35% to 23.44%, leading to 17.94% rise in operating profit to Rs 92.25 crore.''Purchase of finished goods cost fell from 19.65% to 18.90%. ''Employee cost decreased from 16.77% to 16.04%. ''Other expenses rose from 40.22% to 41.68%. ''Selling and administration expenses rose from 23.38% to 26.11%. ''

Other income rose 52.09% to Rs 11.27 crore.''PBIDT rose 20.89% to Rs 103.52 crore.''Provision for interest rose 575.86% to Rs 7.84 crore.''Loan funds remained nil.''Inventories rose to Rs 27.56 crore as of 30 September 2025 from Rs 24.23 crore as of 30 September 2024.''Sundry debtors were higher at Rs 75.68 crore as of 30 September 2025 compared to Rs 59.91 crore as of 30 September 2024.''Cash and bank balance declined from Rs 245.83 crore as of 30 September 2024 to Rs 29.58 crore as of 30 September 2025.''Investments rose to Rs 526.29 crore as of 30 September 2025 from Rs 83.40 crore as of 30 September 2024 .''

PBDT rose 13.27% to Rs 95.68 crore.''Provision for depreciation rose 48.82% to Rs 21.46 crore.''Fixed assets increased to Rs 1,289.81 crore as of 30 September 2025 from Rs 883.28 crore as of 30 September 2024.''Intangible assets increased from Rs 2.98 crore to Rs 4.17 crore.''

Profit before tax grew 5.95% to Rs 74.22 crore.''Share of profit/loss were nil in both the periods.''Provision for tax was expense of Rs 16.75 crore, compared to Rs 18.21 crore.''Effective tax rate was 22.57% compared to 26.00%.

Minority interest decreased 36.84% to Rs 0.12 crore.''Net profit attributable to owners of the company increased 11.04% to Rs 57.35 crore.''

Equity capital stood at Rs 65.57 crore as of 30 September 2025 to Rs 65.57 crore as of 30 September 2024.''Per share face Value remained same at Rs 10.00.''

Promoters' stake was 40.91% as of 30 September 2025 ,compared to 40.91% as of 30 September 2024 .''

For year-to-date (YTD) results analysis.

Net sales (including other operating income) of Jupiter Life Line Hospitals has increased 17.96% to Rs 746.58 crore.''

Operating profit margin has jumped from 22.76% to 22.86%, leading to 18.46% rise in operating profit to Rs 170.67 crore.''Purchase of finished goods cost fell from 19.70% to 19.47%. ''Employee cost decreased from 17.23% to 16.71%. ''Other expenses rose from 40.42% to 40.99%. ''Selling and administration expenses rose from 23.32% to 24.84%. ''

Other income rose 68.93% to Rs 24.09 crore.''PBIDT rose 23.01% to Rs 194.76 crore.''Provision for interest rose 609.69% to Rs 16.11 crore.''Loan funds remained nil.''Inventories rose to Rs 27.56 crore as of 30 September 2025 from Rs 24.23 crore as of 30 September 2024.''Sundry debtors were higher at Rs 75.68 crore as of 30 September 2025 compared to Rs 59.91 crore as of 30 September 2024.''Cash and bank balance declined from Rs 245.83 crore as of 30 September 2024 to Rs 29.58 crore as of 30 September 2025.''Investments rose to Rs 526.29 crore as of 30 September 2025 from Rs 83.40 crore as of 30 September 2024 .''

PBDT rose 14.48% to Rs 178.65 crore.''Provision for depreciation rose 67.77% to Rs 42.68 crore.''Fixed assets increased to Rs 1,289.81 crore as of 30 September 2025 from Rs 883.28 crore as of 30 September 2024.''Intangible assets increased from Rs 2.98 crore to Rs 4.17 crore.''

Profit before tax grew 4.10% to Rs 135.97 crore.''Share of profit/loss were nil in both the periods.''Provision for tax was expense of Rs 34.55 crore, compared to Rs 34.36 crore.''Effective tax rate was 25.41% compared to 26.31%.

Minority interest decreased 43.75% to Rs 0.18 crore.''Net profit attributable to owners of the company increased 5.52% to Rs 101.24 crore.''

Equity capital stood at Rs 65.57 crore as of 30 September 2025 to Rs 65.57 crore as of 30 September 2024.''Per share face Value remained same at Rs 10.00.''

Promoters' stake was 40.91% as of 30 September 2025 ,compared to 40.91% as of 30 September 2024 .''

Full year results analysis.

Net sales (including other operating income) of Jupiter Life Line Hospitals has increased 21.33% to Rs 1302.4 crore.''Operating profit margin has jumped from 22.55% to 23.04%, leading to 23.97% rise in operating profit to Rs 300.11 crore.''Purchase of finished goods cost rose from 17.83% to 19.78%. ''Employee cost decreased from 17.66% to 17.26%. ''Other expenses fell from 42.01% to 39.96%. ''Selling and administration expenses fell from 25.22% to 23.39%. ''

Other income rose 28.57% to Rs 28.35 crore.''PBIDT rose 24.35% to Rs 328.46 crore.''Provision for interest fell 59.34% to Rs 10.71 crore.''Loan funds remained nil.''Inventories rose to Rs 26.46 crore as of 31 March 2025 from Rs 21.34 crore as of 31 March 2024.''Sundry debtors were lower at Rs 43.23 crore as of 31 March 2025 compared to Rs 57.21 crore as of 31 March 2024.''Cash and bank balance declined from Rs 301.25 crore as of 31 March 2024 to Rs 94.98 crore as of 31 March 2025.''Investments rose to Rs 509.92 crore as of 31 March 2025 from Rs 17.01 crore as of 31 March 2024 .''

PBDT rose 33.62% to Rs 317.75 crore.''Provision for depreciation rose 34.69% to Rs 57.08 crore.''Fixed assets increased to Rs 1,158.56 crore as of 31 March 2025 from Rs 789.51 crore as of 31 March 2024.''Intangible assets increased from Rs 2.13 crore to Rs 4.55 crore.''

Profit before tax grew 33.39% to Rs 260.67 crore.''Share of profit/loss were nil in both the periods.''Provision for tax was expense of Rs 66.92 crore, compared to Rs 18.8 crore.''Effective tax rate was 25.67% compared to 9.62%.

Minority interest decreased 62.84% to Rs 0.55 crore.''Net profit attributable to owners of the company increased 10.31% to Rs 193.20 crore.''

Equity capital stood at Rs 65.57 crore as of 31 March 2025 to Rs 65.57 crore as of 31 March 2024.''Per share face Value remained same at Rs 10.00.''

Promoters' stake was 40.91% as of 31 March 2025 ,compared to 40.91% as of 31 March 2024 .''

Cash flow from operating activities increased to Rs 253.30 crore for year ended March 2025 from Rs 114.52 crore for year ended March 2024.''Cash flow used in acquiring fixed assets during the year ended March 2025 stood at Rs 320.73 crore, compared to Rs 85.30 crore during the year ended March 2024.''

Business highlights

In H1 FY26, Average Occupancy Rate was 62.2%. IPD & OPD Volume grew by 0.7% and 11.5% YoY respectively.

The company's Dombivli project is on track and expected to become operational by Q1 FY27. The company began with the construction work for South Pune facility from Q3 FY26, and the Mira'Bhayandar project is expected to Operationalise by CY29.

In H1 FY26, Average Revenue Per Occupied Bed increased 14.5% YoY to Rs 66,100.

Management Comments :
Dr. Ankit Thakker JMD & CEO said, 'It has been an uneventful quarter, with all our existing hospitals performing as per expectations. As outlined earlier, Pune is nearing maturity, and the Indore hospital is showing improved growth following the brownfield expansion that was undertaken earlier this year. The Dombivli Hospital project is progressing on schedule. From this quarter, we have moved towards the interiors, services and finishing stages of the hospital and will begin with team building soon. As committed last quarter, we have begun with the construction work for our South Pune facility from Q3FY26. We hope to commence operations of this facility in CY28. We continue to leverage our operational strengths, clinical excellence and patient-centric approach to drive sustainable growth and reinforce our leadership position in Western India's healthcare sector.'

Jupiter Life Line Hospitals : Consolidated Results

' Quarter ended Year to Date Year ended Particulars 202509 202409 Var.(%) 202509 202409 Var.(%) 202503 202403 Var.(%) Net Sales (including other operating income) 393.63 335.05 17.48 746.58 632.93 17.96 1,302.40 1,073.44 21.33 OPM (%) 23.44 23.35 9 bps 22.86 22.76 10 bps 23.04 22.55 49 bps OP 92.25 78.22 17.94 170.67 144.07 18.46 300.11 242.09 23.97 Other Inc. 11.27 7.41 52.09 24.09 14.26 68.93 28.35 22.05 28.57 PBIDT 103.52 85.63 20.89 194.76 158.33 23.01 328.46 264.14 24.35 Interest 7.84 1.16 575.86 16.11 2.27 609.69 10.71 26.34 -59.34 PBDT 95.68 84.47 13.27 178.65 156.06 14.48 317.75 237.80 33.62 Depreciation 21.46 14.42 48.82 42.68 25.44 67.77 57.08 42.38 34.69 PBT 74.22 70.05 5.95 135.97 130.62 4.10 260.67 195.42 33.39 Share of Profit/(Loss) from Associates 0 0 - 0 0 - 0 0 - PBT before EO 74.22 70.05 5.95 135.97 130.62 4.10 260.67 195.42 33.39 EO Income 0 0 - 0 0 - 0 0 - PBT after EO 74.22 70.05 5.95 135.97 130.62 4.10 260.67 195.42 33.39 Taxation 16.75 18.21 -8.02 34.55 34.36 0.55 66.92 18.8 255.96 PAT 57.47 51.84 10.86 101.42 96.26 5.36 193.75 176.62 9.70 Minority Interest (MI) 0.12 0.19 -36.84 0.18 0.32 -43.75 0.55 1.48 -62.84 Net profit 57.35 51.65 11.04 101.24 95.94 5.52 193.2 175.14 10.31 P/(L) from discontinued operations net of tax 0 0 - 0 0 - 0 0 - Net profit after discontinued operations 57.35 51.65 11.04 101.24 95.94 5.52 193.2 175.14 10.31 EPS (Rs)* 8.75 7.88 11.04 15.44 14.63 5.52 29.47 26.71 10.31 * EPS is on current equity of Rs 65.57 crore, Face value of Rs 10, Excluding extraordinary items. # EPS is not annualised bps : Basis points EO : Extraordinary items Figures in Rs crore Source: Capitaline Corporate Database